Venous thromboembolism studies of apixaban and its clinical use
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.44, ss.41-46, 2016 (ESCI)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 44
- Basım Tarihi: 2016
- Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.41-46
- İstanbul Üniversitesi Adresli: Evet
Özet
Traditional treatment of venous tromboembolism requieres initiation of anticoagulation with heparin and low molecular weight heparin which is followed by warfarin use between 3-6 months. Warfarin has a narrow therapeutic range and a wide range of food interactions. To overcome the difficulties of the treatment with warfarin, new oral anticoagulant agents (NOACs) had been discovered after long years of research processes. In this review, the use of these agents, especially of apixaban, will be discussed in the treatment of venous thromboembolism.